Biotech and medical business blog
Visit BioHealth Investor
Short Interest Volume Changes: MAJOR BIOTECH (AMGN, GILD, BIIB, CELG, GENZ)
Posted on June 25, 2008
We ran a screen of the top five NASDAQ biotech stocks by market cap to look at the short interest changes from the end of May to mid-June. Amgen Inc. (NASDAQ: AMGN) had the largest gains in short selling by far and the others were mixed. We also screened Gilead Sciences Inc. [...]...
Original article linkTags:
biotech , short selling default explanation





Subscribe to BioHealth Investor